Page 14 - Read Online

P. 14

Shetty. Plast Aesthet Res 2022;9:47 https://dx.doi.org/10.20517/2347-9264.2022.41 Page 9 of 9

Financial support and sponsorship
None.

Conflicts of interest
The author declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

REFERENCES
1. Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: a comprehensive review. Ann Plast Surg 2007;59:464-72. DOI PubMed
2. Mihara M, Hara H, Hayashi Y, et al. Pathological steps of cancer-related lymphedema: histological changes in the collecting lymphatic
vessels after lymphadenectomy. PLoS One 2012;7:e41126. DOI PubMed PMC
3. Yamamoto T, Yamamoto N, Yoshimatsu H, Narushima M, Koshima I. Factors associated with lymphosclerosis: an analysis on 962
lymphatic vessels. Plast Reconstr Surg 2017;140:734-41. DOI PubMed
4. Granzow JW, Soderberg JM, Kaji AH, Dauphine C. Review of current surgical treatments for lymphedema. Ann Surg Oncol
2014;21:1195-201. DOI PubMed
5. Calderwood A, Thompson B, Ho-shon K, Suami H. Overview of magnetic resonance lymphography for imaging lymphoedema. PAR
2021. DOI
6. Yang JC, Wu SC, Chiang MH, Lin WC. Targeting reflux-free veins with a vein visualizer to identify the ideal recipient vein
preoperatively for optimal lymphaticovenous anastomosis in treating lymphedema. Plast Reconstr Surg 2018;141:793-7. DOI
PubMed
7. Seki Y, Kajikawa A, Asai R, et al. Functional lymphaticovenular anastomosis for peripheral lymphedema: incision selection methods
with muscle pumping. PAR 2021. DOI
8. Garza RM, Beederman M, Chang DW. Physical and functional outcomes of simultaneous vascularized lymph node transplant and
lymphovenous bypass in the treatment of lymphedema. Plast Reconstr Surg 2022;150:169-80. DOI PubMed
9. Mitsumori LM, McDonald ES, Neligan PC, Maki JH. Peripheral magnetic resonance lymphangiography: techniques and applications.
Tech Vasc Interv Radiol 2016;19:262-72. DOI PubMed
10. Mazzei FG, Gentili F, Guerrini S, et al. MR lymphangiography: a practical guide to perform it and a brief review of the literature from
a technical point of view. Biomed Res Int 2017;2017:2598358. DOI PubMed PMC
11. Hawkins CM. Building a radiology service line: key elements and necessary actions. Curr Probl Diagn Radiol 2016;45:107-10. DOI
PubMed
12. Guerrini S, Gentili F, Mazzei FG, Gennaro P, Volterrani L, Mazzei MA. Magnetic resonance lymphangiography: with or without
contrast? Diagn Interv Radiol 2020;26:587-95. DOI PubMed PMC
13. Chan S. The importance of strategy for the evolving field of radiology. Radiology 2002;224:639-48. DOI PubMed
14. White RD, Weir-McCall JR, Budak MJ, Waugh SA, Munnoch DA, Sudarshan TA. Contrast-enhanced magnetic resonance
lymphography in the assessment of lower limb lymphoedema. Clin Radiol 2014;69:e435-44. DOI PubMed
15. Notohamiprodjo M, Baumeister RG, Jakobs TF, et al. MR-lymphangiography at 3.0 T - a feasibility study. Eur Radiol 2009;19:2771-
8. PubMed
16. Ripley B, Wilson GJ, Lalwani N, Briller N, Neligan PC, Maki JH. Initial clinical experience with dual-agent relaxation contrast for
isolated lymphatic channel Mapping. Radiology 2018;286:705-14. DOI PubMed
17. Maki JH, Neligan PC, Briller N, Mitsumori LM, Wilson GJ. Dark blood magnetic resonance lymphangiography using dual-agent
relaxivity contrast (DARC-MRL): a novel method combining gadolinium and iron contrast agents. Curr Probl Diagn Radiol
2016;45:174-9. DOI PubMed
18. U.S. Food & Drug Administration. FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions
to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol). Available from:
https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-strengthens-warnings-and-changes-
prescribing-instructions-decrease [Last accessed on 29 Jul 2022].

9 10 11 12 13 14 15 16 17 18 19